Avantor (NYSE:AVTR) Price Target Raised to $25.00

Avantor (NYSE:AVTR - Get Free Report) had its target price lifted by investment analysts at Deutsche Bank Aktiengesellschaft from $23.00 to $25.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a "hold" rating on the stock. Deutsche Bank Aktiengesellschaft's price target would suggest a potential upside of 2.92% from the stock's previous close.

Several other brokerages also recently issued reports on AVTR. Barclays upped their price target on shares of Avantor from $27.00 to $30.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 10th. Royal Bank of Canada upped their target price on shares of Avantor from $28.00 to $29.00 and gave the company an "outperform" rating in a research report on Thursday, February 15th. Evercore ISI upped their target price on shares of Avantor from $26.00 to $28.00 and gave the company an "outperform" rating in a research report on Thursday, April 4th. Citigroup upped their target price on shares of Avantor from $24.00 to $30.00 and gave the company a "buy" rating in a research report on Thursday, February 15th. Finally, UBS Group upped their target price on shares of Avantor from $25.00 to $29.00 and gave the company a "buy" rating in a research report on Thursday, February 15th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $26.71.

Avantor Stock Performance

Avantor stock traded down $0.09 on Thursday, hitting $24.29. The company's stock had a trading volume of 4,195,951 shares, compared to its average volume of 5,711,768. The firm has a market cap of $16.48 billion, a P/E ratio of 50.60, a price-to-earnings-growth ratio of 1.55 and a beta of 1.37. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 1.00. The company has a fifty day moving average price of $24.91 and a 200-day moving average price of $22.44. Avantor has a one year low of $16.63 and a one year high of $26.16.

Avantor (NYSE:AVTR - Get Free Report) last posted its earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.03. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The business had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.70 billion. During the same quarter in the prior year, the firm earned $0.32 EPS. The firm's quarterly revenue was down 4.0% compared to the same quarter last year. On average, equities analysts anticipate that Avantor will post 1.01 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP James Bramwell sold 6,203 shares of the stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the completion of the sale, the executive vice president now directly owns 101,143 shares of the company's stock, valued at approximately $2,476,992.07. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On Avantor

Hedge funds have recently made changes to their positions in the business. Raymond James & Associates grew its stake in shares of Avantor by 84.8% during the 4th quarter. Raymond James & Associates now owns 1,165,646 shares of the company's stock worth $26,612,000 after acquiring an additional 534,901 shares in the last quarter. DAVENPORT & Co LLC grew its stake in shares of Avantor by 17.6% during the 4th quarter. DAVENPORT & Co LLC now owns 2,283,767 shares of the company's stock worth $52,430,000 after acquiring an additional 342,452 shares in the last quarter. Vaughan Nelson Investment Management L.P. grew its stake in shares of Avantor by 8.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 2,508,557 shares of the company's stock worth $57,269,000 after acquiring an additional 194,031 shares in the last quarter. Northern Trust Corp grew its stake in shares of Avantor by 9.0% in the third quarter. Northern Trust Corp now owns 4,129,447 shares of the company's stock valued at $87,049,000 after buying an additional 342,553 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System grew its stake in shares of Avantor by 12.7% in the third quarter. State Board of Administration of Florida Retirement System now owns 658,563 shares of the company's stock valued at $13,883,000 after buying an additional 74,078 shares in the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.